돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 38576생성일: 2026년 10월 25일

1-(2-Pyridyl)piperazine → N-(3,4-Dichlorophenyl)-7-[(2E)-4-(4-pyridin-2-ylpiperazin-1-yl)but-2-enoyl]-5,6,7,8-tetrahydropyrido[4',3':4,5]thieno[2,3-d]pyrimidin-4-amine

https://huagongshe.com/reaction/38576

반응식

참여 물질

역할이름HCID투입량
반응물1-(2-Pyridyl)piperazineHCID 94459—
반응물7-[(2E)-4-Chlorobut-2-enoyl]-N-(3,4-dichlorophenyl)-5,6,7,8-tetrahydropyrido[4',3':4,5]thieno[2,3-d]pyrimidin-4-amineHCID 58116806—
용매DimethylformamideHCID 6228—
생성물N-(3,4-Dichlorophenyl)-7-[(2E)-4-(4-pyridin-2-ylpiperazin-1-yl)but-2-enoyl]-5,6,7,8-tetrahydropyrido[4',3':4,5]thieno[2,3-d]pyrimidin-4-amineHCID 2522109779.7%

반응 단계

To a suspension of Example 59A (80 mg, 0.16 mmol) in DMF (1 mL) was added 1-pyridin-2-ylpiperazine (52 mg, 0.32 mmol), and the mixture was stirred at rt for 3 h and then heated to 50° C. for 4 h. After purification by preparative HPLC, the product crystallized upon trituration with dichloromethane to yield 74 mg (79%) of the title compound.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US08524722B2
출처 데이터셋uspto-grants-2013_09
ORD IDord-8b0cbf93ec1948008fc11b3cfa0b0809
출처 메모uspto-grants-2013_09